-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 ImnEo+Rwssi/0ZFpT/wolPoWV1ewYjvCzFiHBOnQPJZUSSncFP2Ett2+LjfEh1Sm
 c+HLL90plv7qYUvBUIi5eQ==

<SEC-DOCUMENT>0000919574-09-002058.txt : 20090209
<SEC-HEADER>0000919574-09-002058.hdr.sgml : 20090209
<ACCEPTANCE-DATETIME>20090209162650
ACCESSION NUMBER:		0000919574-09-002058
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090205
FILED AS OF DATE:		20090209
DATE AS OF CHANGE:		20090209

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ZACKS ANDREW
		CENTRAL INDEX KEY:			0001437688

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24241
		FILM NUMBER:		09581574

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		212-332-7265

	MAIL ADDRESS:	
		STREET 1:		C/O CONUS PARTNERS, INC.
		STREET 2:		49 WEST 38TH STREET, 11TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PANACOS PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001040017
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				113238476
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		134 COOLIDGE AVE
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-926-1551

	MAIL ADDRESS:	
		STREET 1:		134 COOLIDGE AVE
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	V I TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19980209

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			CONUS PARTNERS INC
		CENTRAL INDEX KEY:			0001174784

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24241
		FILM NUMBER:		09581573

	BUSINESS ADDRESS:	
		STREET 1:		49 WEST 38TH STREET
		STREET 2:		11TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		212-332-7265

	MAIL ADDRESS:	
		STREET 1:		49 WEST 38TH STREET
		STREET 2:		11TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>p963008_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-02-05</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001040017</issuerCik>
        <issuerName>PANACOS PHARMACEUTICALS, INC.</issuerName>
        <issuerTradingSymbol>PANC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001174784</rptOwnerCik>
            <rptOwnerName>CONUS PARTNERS INC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>49 WEST 38TH STREET</rptOwnerStreet1>
            <rptOwnerStreet2>11TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10018</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001437688</rptOwnerCik>
            <rptOwnerName>ZACKS ANDREW</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CONUS PARTNERS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>49 WEST 38TH STREET, 11TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10018</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7263489</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>52600</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">These shares of Common Stock (the &quot;Shares&quot;) of Panacos Pharmaceuticals, Inc. (the &quot;Issuer&quot;) are held in the accounts of
 private investment vehicles over which Conus Partners, Inc. and Andrew Zacks (the &quot;Reporting
 Persons&quot;) each has investment discretion.  Conus Partners, Inc. has investment discretion over the Shares because it is the
 investment adviser to such private investment vehicles.  Andrew Zacks has investment discretion over
 the Shares because he is the Managing Director of Conus Partners, Inc. The Reporting Persons hereby disclaim beneficial
 ownership over these Shares except to the extent of their pecuniary interest therein. This report shall not be deemed an
 admission that the Reporting Persons are the beneficial owners of these Shares for purposes of Section 16 of the Securities
 Exchange Act of 1934, as amended, or for any other purpose.</footnote>
        <footnote id="F2">These Shares are held in an account over which Andrew Zacks has exclusive investment discretion.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Conus Partners, Inc. By: Andrew Zacks Title: Managing Director /s/ Andrew Zacks</signatureName>
        <signatureDate>2009-02-09</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Andrew Zacks  /s/ Andrew Zacks</signatureName>
        <signatureDate>2009-02-09</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----